Brazil Plans Own Making Of H1N1 Vaccine To Avoid Private-Sector Pitfalls
This article was originally published in PharmAsia News
Brazil's Ministry of Health plans to produce its own H1N1 influenza vaccine to avoid the pitfalls of relying on the private sector constantly challenged by a changing economic landscape.
You may also be interested in...
Increasing savvy around cybersecurity issues is driving regulators and trade groups to update their approach to the area, speakers from the US FDA and the American Medical Association said at this week’s FDA/CMS Summit.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.